SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Oct 18, 2006	View HTML 0001144204-06-042742.pdf 0001144204-06-042742.rtf 0001144204-06-042742.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Oct 16, 2006	View HTML 0001144204-06-042300.pdf 0001144204-06-042300.rtf 0001144204-06-042300.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Oct 10, 2006	View HTML 0001144204-06-041451.pdf 0001144204-06-041451.rtf 0001144204-06-041451.xls
REGDEX	REGDEX	Oct 10, 2006	View HTML
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Oct 02, 2006	View HTML 0001144204-06-040558.pdf 0001144204-06-040558.rtf 0001144204-06-040558.xls
F-3/A	Amendment to a previously filed F-3	Sep 29, 2006	View HTML 0000950123-06-012163.pdf 0000950123-06-012163.rtf 0000950123-06-012163.xls
F-3/A	Amendment to a previously filed F-3	Sep 29, 2006	View HTML 0000950123-06-012164.pdf 0000950123-06-012164.rtf 0000950123-06-012164.xls
EFFECT	EFFECT	Sep 29, 2006	View HTML 9999999995-06-001703.pdf 9999999995-06-001703.rtf
EFFECT	EFFECT	Sep 29, 2006	View HTML 9999999995-06-001704.pdf 9999999995-06-001704.rtf
EFFECT	EFFECT	Sep 29, 2006	View HTML 9999999995-06-001709.pdf 9999999995-06-001709.rtf

Data provided by Kaleidoscope.